Skip to main content

Financial Performance

Elevance Health Revenue & Financials

Revenue

$199.1B (FY2025)

Market Cap

$80B

Employees

97,100

What is Elevance Health's revenue?

Elevance Health had $199.1B in revenue for fiscal year 2025, up 12.5% from 2024.

Latest revenue
$199.1B (FY2025)
Year-over-year
+12.5%
Growth rate (CAGR)
9.9% over 9 years
Peak revenue
$199.1B (FY2025)
Years of data
10
Employees
97,100
What is Elevance Health's operating income?
Elevance Health reported operating income of $7.2B for fiscal year 2025. sec.gov
How many employees does Elevance Health have?
Elevance Health has about 97,100 employees.

Financial Analysis

Revenue rose from $171.3B in 2023 to $177.0B in 2024 and $199.1B in 2025, helped by premium-rate increases, acquisitions and Medicare Advantage growth that offset Medicaid attrition. Net income was $5.662B in 2025 on operating income of $7.199B. Growth slowed in 2026 as the company deliberately shrank unprofitable Medicaid, Medicare Advantage and employer risk business: operating revenue was $49.5B in Q1 2026 and $49.8B in Q2 2026. In July 2026 Elevance raised full-year guidance to at least $20.10 GAAP diluted EPS and at least $27.00 adjusted EPS, with operating cash flow of at least $6.0B, and paid a $1.72 quarterly dividend. Elevance Health (formerly Anthem) is a massive American health insurance provider, maintaining a staggering market valuation generally exceeding $120 billion.

Revenue Trend Analysis

YoY Change

+12.5%

9-Year CAGR

+9.9%

Peak Year

2025

Trend

Consistent Growth

Elevance Health, Inc. has 10 full fiscal year figures on this page, compounding at +9.9% annually over 9 years. The most recent year saw a 12.5% increase versus the prior year. Annual revenue peaked in fiscal year 2025 at $199.1B. Of 9 comparable year-over-year steps, 9 showed growth and 0 showed a decline.

Annual revenue history

Fiscal YearRevenueOperating IncomeNet IncomeYoY ChangeSource
FY2025$199.1B$7.2Bfiling—+12.5%sec.gov

Total revenues were $199.125B in FY2025.

FY2024$177B$7.9Bfiling—+3.3%sec.gov

Total revenues were $177.011B in FY2024.

FY2023$171.3B$8.5Bfiling—+9.4%sec.gov

Total revenues were $171.340B in FY2023.

FY2022$156.6B$8.3B$5.9B+13.0%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2025-02-20)

Fiscal year ended 2022-12-31.

FY2021$138.6B$7.6B$6.2B+13.8%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2024-02-21)

Fiscal year ended 2021-12-31.

FY2020$121.9B$6.4B$4.6B+16.9%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2023-02-15)

Fiscal year ended 2020-12-31.

FY2019$104.2B$6B$4.8B+13.1%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2022-02-16)

Fiscal year ended 2019-12-31.

FY2018$92.1B$5.4B$3.8B+2.3%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2021-02-18)

Fiscal year ended 2018-12-31.

FY2017$90B$4.2B$3.8B+6.1%Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2020-02-19)

Fiscal year ended 2017-12-31.

FY2016$84.9B$4.8B$2.5B—Elevance Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2019-02-20)

Fiscal year ended 2016-12-31.

Click any row to see year details.

Elevance Health, Inc. balance sheet and cash flow

Balance-sheet figures are as of each fiscal year end; cash-flow figures cover the fiscal year. Taken from the company's annual report on Form 10-K, linked on each row. Free cash flow here is operating cash flow less capital expenditures, calculated by CorpDigest.

Fiscal YearOperating cash flowCapital expendituresTotal assetsTotal liabilitiesShareholders' equityFree cash flowSource
FY2025ended Dec 31, 2025$4.3B$1.1B$121.5B$77.5B$43.9B$3.2BForm 10-K
FY2024ended Dec 31, 2024$5.8B$1.3B$116.9B$75.5B$41.3B$4.6BForm 10-K
FY2023ended Dec 31, 2023$8.1B$1.3B$108.9B$69.5B$39.3B$6.8BForm 10-K
FY2022ended Dec 31, 2022$8.4B$1.2B$102.8B$66.4B$36.2B$7.2BForm 10-K
FY2021ended Dec 31, 2021$8.4B$1.1B$97.5B$61.3B$36.1B$7.3BForm 10-K
FY2020ended Dec 31, 2020$10.7B$1B$86.6B$53.4B$33.2B$9.7BForm 10-K
FY2019ended Dec 31, 2019$6.1B$1.1B$77.5B$45.7B$31.7B$5BForm 10-K
FY2018ended Dec 31, 2018$3.8B$1.2B$71.6B$43B$28.5B$2.6BForm 10-K
FY2017ended Dec 31, 2017$4.2B$791M$70.5B$44B$26.5B$3.4BForm 10-K
FY2016ended Dec 31, 2016$3.3B$584M$65.1B$40B$25.1B$2.7BForm 10-K

Keep researching Elevance Health

Elevance Health Revenue and Financial FAQ

What was Elevance Health's revenue in 2025?

$199.125B, up from $177.0B in 2024, with net income of $5.662B.

What were Elevance's Q2 2026 results?

Operating revenue was $49.8B, up 0.8%. Diluted EPS was $6.71 and adjusted diluted EPS was $7.45.

What is Elevance's 2026 guidance?

As of July 2026: at least $20.10 GAAP diluted EPS, at least $27.00 adjusted EPS, and at least $6.0B of operating cash flow.

Does Elevance pay a dividend?

Yes. It paid $1.72 per share per quarter in 2026 and repurchased $234M of stock in Q2 2026.

Why did Elevance's membership fall in 2026?

A large fee-based employer customer moved away, and the company accepted attrition in ACA and Medicaid plans while exiting lower-margin markets.

Is Elevance Health a non-profit?

No. While it started as a non-profit mutual company (owned by its policyholders), it executed a massive "demutualization" in 2001, going public on the stock market. Since then, it has generated massive, highly reliable profits for its Wall Street shareholders.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page
CorpDigest. "Elevance Health Revenue & Financials." CorpDigest, https://corpdigest.com/company/elevance-health/financials.
Embed this data
<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Elevance Health reported $199.1B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/elevance-health/financials" target="_blank" rel="noopener">CorpDigest — Elevance Health financials</a></div>

Related Financial Audits

Compare revenue, net income, and market cap scale

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.